A solution mediated transformation between two co-crystal phases has been observed for the p-5 toluensulfonamide/triphenylphosphine oxide co-crystal system. This system has two known co-crystals with 1:1 and 3:2 stoichiometry respectively, and the ternary phase diagram (TPD) for the system has been determined in acetonitrile previously. By manipulating the solution composition in this 10 solvent to a region of the TPD where the 1:1 co-crystal is stable, the 3:2 co-crystal could be observed to convert to the 1:1 co-crystal. The corresponding transformation was true for the 1:1 co-crystal in a region of the TPD where the 3:2 cocrystal is stable; the 1:1 co-crystal converted to the 3:2 co-15 crystal.
The creation of co-crystals has recently gained increased interest within the solid-state community as a route for the modification of the physico-chemical properties of active pharmaceutical 20 ingredients (APIs). [1] [2] [3] [4] [5] While the creation of such materials has been repeatedly demonstrated, studies into the crystallisation processes and transformations between such materials has only recently received attention. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] However, such understanding is required to fully develop suitable crystallisation processes for the 25 industrial synthesis of pharmaceutical co-crystals.
The key source of information for the design of a solutionbased co-crystallisation is the ternary phase diagram (TPD), which indicates the thermodynamically stable phase for a given composition. 6 While previous studies have, in general, focused on 30 the development of methodologies for the construction of TPDs and their application in the growth of a stable phase, less work has been carried out on the kinetics of the crystallisation and influence of conditions on the growth of the differing phases. The solution mediated transformation between polymorphic co-35 crystals has been reported for the carbamazepine/isonicotinamide system. 18 The carbamazepine/nicotinamide system has been investigated to study both the competing crystallisation kinetics of the differing phases in regions where two solid phases are stable 11 and the solution mediated transformation from 40 carbamazepine to the co-crystal through the introduction of enough solid nicotinamide to shift the composition into a different region of the TPD. 14 In the carbamazepine/nicotinamide system only a single co-crystal phase is known and so only the conversion between the starting materials and the co-crystal are 45 possible. While a number of systems exhibit co-crystals of differing stoichiometry and the identification of the regions of the TPD where the differing phases are stable has been reported, 16, 19, 20 the conversion process between these differing cocrystal phases has not been fully investigated.
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It has been shown for some co-crystal systems that the relative stability of co-crystals with differing stoichiometries can be altered through the choice of solvent. For example, the benzoic acid/isonicotinamide pair has two co-crystals: one with a 1:1 composition and one with a 2:1 composition. 21 crystallisation of the 1:1 phase after 10 hours. 13 Understanding the balance of stability between the differing phases and the choice of solvent is thus required to design suitable conditions for the controlled growth of selected phases. Such understanding was recently applied to the successful growth of crystals suitable for 65 single crystal structure determination of the 1:2 malic acid and caffeine co-crystal. This malic acid/caffeine system exists in two stoichiometries (1:1 and 1:2) and both phases are readily obtainable through solid-state grinding. However, only crystals of the 1:1 phase suitable for single crystal structure solution could 70 be obtained by slow evaporation of dichloromethane solution. 5 In contrast, only poorly diffracting crystals of the 1:2 co-crystal could be produced through anti-solvent addition of cyclohexane to a saturated 1:2 solution in 15:1 chloroform/methanol mixture. Investigations into the relative solubilities of the components 75 indicated significant differences between the two components for the majority of solvents and construction of the ternary phase diagram for malic acid/caffeine/acetone indicated that the 1:2 system was metastable for this system. 20 Selection of a solvent that reduced the differences in solubility lead to the identification 80 of a system where both co-crystal phase were stable. Construction of the TPD for malic acid/caffeine/ethyl acetate allowed for the controlled growth of the 1:2 co-crystal. 22 For polymorphic systems, solution mediated transformations are an important process for the conversion of metastable phases 85 into stable crystalline phases. 23, 24 While the general mechanism is the dissolution of the metastable phase and regrowth of the stable one, these conversions may also occur through heterogeneous nucleation driven by an epitaxial interaction between the two phases due to similarities in selected surfaces of the two forms. For example, the solution mediated transformation of  to  glutamic acid occurs by nucleation of the  phase on the {111} faces of the  phase. [25] [26] [27] [28] Recently, work in identifying the different possible transformation scenarios for polymorph transformations has highlighted the balance between dissolution 95 of the metastable phase and the nucleation and growth of the stable phase. 29 Similar factors will control the transformation of metastable co-crystal phases to stable co-crystal phases, however unlike polymorphic systems the stability of a given co-crystal is dependant on the composition of the solution. Thus the 100 transformation process can be easily studied by the addition of crystals of one co-crystal into a solution with a composition where the other co-crystal is stable.
The system comprising p-toulenesulfonamide (TSA) and triphenylphosphine oxide (PH 3 PO) was initially reported to form 105 as a 3:2 co-crystal 30 but subsequent study has identified an additional 1:1 co-crystal phase. 16 Construction of TPDs in acetonitrile and dichloromethane has allowed for the identification of distinct solution compositions where each individual co-crystal is the thermodynamically stable phase.
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Knowledge of these solution compositions allows for preparation of a solution saturated with respect to one specific co-crystal form. This study investigated the behaviour of the 3:2 co-crystal of the TSA/ PH 3 PO system when it was placed in a solution saturated with respect to the 1:1 co-crystal, and vice versa. The subsequent solution mediated co-crystal transformation was 5 observed with optical microscopy in real time, and confirmed with PXRD on completion.
The saturation concentrations of TSA and Ph 3 PO within the 10 region in acetonitrile solution where the 1:1 and 3:2 co-crystal are respectively stable, were initially measured using a Crystal 16 TM system from Avantium Technologies (Figure 1) . † For this system, both composition lines for the two co-crystals cross the 1:1 cocrystal solubility, confirming that the 1:1 co-crystal displays 15 congruent dissolution, while the 3:2 displays incongruent dissolution as shown by the previously determined TPD. 16 The behaviour of each co-crystal in a solution saturated with respect to the other co-crystal respectively was investigated with optical microscopy. The 3:2 crystal undergoes dissolution initially, and additional crystals appear independently of the seed crystal (Figure 2) . Growth of the new crystals continued until all the seed phase had 40 dissolved. PXRD of the resulting phase confirmed that the crystals were the 1:1 co-crystal (Figure 4) .
During the conversion of the 1:1 crystal, the newly formed crystals cluster closely around the seed crystal and may be 45 associated with the dissolving surface ( Figure 3 ). As each experiment is undertaken without stirring, a local increase in the supersaturation level surrounding the dissolving crystal may occur. This would increase the probability of nucleation and results in the growth of the expected phase in the vicinity of the 50 seed crystal. The final product in this case was confirmed as the 3:2 co-crystal using PXRD. The recorded images do not clearly define if heterogeneous nucleation occurred on the surface of the co-crystal. As the seed crystals are poorly formed, the habits of the crystals have not 10 been characterised and so identification of the molecular features on each surface preventing such interactions is limited. However, prediction of the morphology by BFDH gives qualitatively similar results to the experimental shapes (Figures 6, 7) . From the predicted morphologies, the 1:1 co-crystal is bounded by 15 predominately aromatic functionalities (Figure 6 ), while the 3:2 co-crystal has an even mixture of aromatic and sulfonamide functional group present on the surfaces (Figure 7 ). Thus the dominant faces of the two phases lack complementary surfaces and the potential for strong directional interactions to direct a 20 surface to surface interaction as observed in the epitaxially driven polymorphic transformations. 23 Lattice matching calculations using epicalc 31 also indicate that there is no lattice registry between the predicted dominant faces of either phase. 
Conclusions
The solution mediated transformation between two co-crystal phases has been demonstrated for the ptoulenesulfonamide/triphenylphosphine oxide system in acetonitrile. In this system no surface interaction appears to occur
